Cancer BiologybioRxiv
The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer
S. Cheng, N. Prieto-Dominguez, S. Yang…·X. Yu
This study shows YAP1 is increased in high-grade prostate adenocarcinoma but reduced in neuroendocrine prostate cancer, with YAP1 loss activating Wnt/beta-Catenin signaling linked to NEPC development.
DOI 10.1038/s41391-020-0229-z